MANH
Bearish signalScored 2026-08-13 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
Manhattan Associates, Inc.
- Nom
- Manhattan Associates, Inc.
- Secteur
- Technology
- Industrie
- Software - Application
- Bourse
- NASDAQ
- Capitalisation
- $13.9B
- Employés
- 4,100
- PDG
- Eric A. Clark
- Site web
- https://www.manh.com
- Marché
- DSGXSPSCTRAK
Manhattan Associates, Inc. develops comprehensive software solutions to manage and optimize supply chains, inventory, and omni-channel operations. Their product portfolio features Manhattan SCALE, a suite of logistics execution tools covering aspects like trading partner management, yard optimization, warehouse management, and transportation execution. Additionally, they offer Manhattan Active, which provides integrated enterprise and in-store omni-channel solutions. The company also supplies specialized solutions for inventory optimization, planning, and allocation. Supporting these offerings are a range of services, including ongoing maintenance (customer support and software enhancements), professional services (solution planning, implementation, and consulting), and training and change management programs. Beyond software, Manhattan Associates also resells complementary hardware such as computer equipment, radio frequency (RF) terminal networks, RFID readers, barcode printers and scanners, and other peripherals. They distribute their products through a direct sales force and via strategic partnership agreements. Serving a diverse global clientele, their industry reach includes grocery, food and beverage, manufacturing, medical and pharmaceutical, retail, third-party logistics (3PLs), and wholesale. With operations spanning the Americas, Europe, the Middle East, Africa, and the Asia Pacific, Manhattan Associates, Inc. was founded in 1990 and is headquartered in Atlanta, Georgia.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 4 579 titres (~893 100,68 $ US)
- Insiders
- Clark Eric AndrewHollembaek Linda T.
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$1,897,931
Avg sell (VWAP, 90d window) $195.30 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-11
- Last synced
-
2026-08-21 23:36:53
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-11 | Clark Eric Andrew | Sell · S | 3,000 | $197.76 | $593,280 | Form 4 |
| 2026-08-06 | Hollembaek Linda T. | Sell · S | 1,579 | $189.88 | $299,821 | Form 4 |
| 2026-07-30 | Gantt James Stewart | Sell · S | 5,139 | $195.53 | $1,004,831 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-01-13 | Rob Bresnahan | Sale | $1,001 - $15,000 |
| 2022-05-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-02-17 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2019-06-24 | Donna Shalala | Sale (Full) | $1,001 - $15,000 |
Signal
Bearish signalScored 2026-08-13 Drivers: fundamentals. Moteurs : fondamentaux.
MANH exhibits genuinely strong financial fundamentals — high ROIC/ROE, expanding margins, and robust cash flow generation — yielding a composite health score of 82.5, but the event-driven overlay is decisively negative…
The first sentence of the analysis written for MANH on 2026-08-13 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 1.28 · operating margin 26%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 55.7% | 54.2% | 53.0% | 52.4% | 53.9% | |
| Ebit Margin | 26.4% | 25.6% | 23.0% | 20.6% | 20.2% | |
| Ebitda Margin | 27.0% | 26.2% | 23.6% | 21.5% | 21.4% | |
| Operating Profit Margin | 26.1% | 25.1% | 22.6% | 19.9% | 20.2% | |
| Pretax Profit Margin | 26.4% | 25.6% | 23.0% | 20.6% | 20.2% | |
| Continuous Operations Profit Margin | 20.3% | 20.9% | 19.0% | 16.8% | 16.6% | |
| Net Profit Margin | 20.3% | 20.9% | 19.0% | 16.8% | 16.6% | |
| Bottom Line Profit Margin | 20.3% | 20.9% | 19.0% | 16.8% | 16.6% | |
| Current Ratio | 1.279 | 1.257 | 1.310 | 1.316 | 1.640 | |
| Quick Ratio | 1.279 | 1.257 | 1.310 | 1.316 | 1.640 | |
| Solvency Ratio | 0.431 | 0.490 | 0.461 | 0.395 | 0.410 | |
| Cash Ratio | 0.721 | 0.665 | 0.740 | 0.714 | 1.059 | |
| Price To Earnings Ratio | 47.613 | 75.910 | 75.287 | 59.220 | 89.362 | |
| Price To Earnings Growth Ratio | 21.188 | 3.101 | 1.905 | 3.324 | 3.309 | |
| Forward Price To Earnings Growth Ratio | 21.188 | 3.101 | 1.905 | 3.324 | 3.309 | |
| Price To Earnings Diluted Ratio | 48.142 | 76.991 | 76.355 | 59.803 | 90.401 | |
| Price To Earnings Diluted Growth Ratio | 18.775 | 3.147 | 1.962 | 3.318 | 3.415 | |
| Price To Book Ratio | 33.297 | 55.383 | 47.831 | 33.598 | 39.359 | |
| Price To Sales Ratio | 9.692 | 15.893 | 14.332 | 9.934 | 14.865 | |
| Price To Free Cash Flow Ratio | 28.022 | 57.859 | 55.118 | 44.036 | 54.453 | |
| Price To Operating Cash Flow Ratio | 26.910 | 56.157 | 54.060 | 42.421 | 53.272 | |
| Debt To Assets Ratio | 0.134 | 0.063 | 0.026 | 0.025 | 0.043 | |
| Debt To Equity Ratio | 0.357 | 0.160 | 0.064 | 0.062 | 0.092 | |
| Debt To Capital Ratio | 0.263 | 0.138 | 0.060 | 0.058 | 0.085 | |
| Long Term Debt To Capital Ratio | 0.151 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 2.667 | 2.533 | 2.420 | 2.514 | 2.153 | |
| Working Capital Turnover Ratio | 9.388 | 9.641 | 8.718 | 5.920 | 4.478 | |
| Operating Cash Flow Ratio | 0.854 | 0.737 | 0.673 | 0.569 | 0.744 | |
| Operating Cash Flow Sales Ratio | 0.360 | 0.283 | 0.265 | 0.234 | 0.279 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.960 | 0.971 | 0.981 | 0.963 | 0.978 | |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 3.466 | 6.172 | 13.915 | 12.771 | 7.997 | |
| Capital Expenditure Coverage Ratio | 25.197 | 34.006 | 52.055 | 27.270 | 46.111 | |
| Dividend Paid And Capex Coverage Ratio | 25.197 | 34.006 | 52.055 | 27.270 | 46.111 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 35.126 | 59.858 | 59.508 | 44.960 | 67.785 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 55.7% | ▲1.5% | ▲1.9% |
| Ebit Margin | 26.4% | ▲0.8% | ▲3.3% |
| Ebitda Margin | 27.0% | ▲0.8% | ▲3.1% |
| Operating Profit Margin | 26.2% | ▲1.1% | ▲3.4% |
| Pretax Profit Margin | 26.4% | ▲0.8% | ▲3.3% |
| Continuous Operations Profit Margin | 20.3% | ▼-0.6% | ▲1.6% |
| Net Profit Margin | 20.3% | ▼-0.6% | ▲1.6% |
| Bottom Line Profit Margin | 20.3% | ▼-0.6% | ▲1.6% |
| Current Ratio | 1.280 | ▲0.022 | ▼-0.081 |
| Quick Ratio | 1.280 | ▲0.022 | ▼-0.081 |
| Solvency Ratio | 0.431 | ▼-0.059 | ▼-0.006 |
| Cash Ratio | 0.721 | ▲0.056 | ▼-0.059 |
| Price To Earnings Ratio | 47.613 | ▼-28.297 | ▼-21.866 |
| Price To Earnings Growth Ratio | 21.188 | ▲18.086 | ▲14.622 |
| Forward Price To Earnings Growth Ratio | 21.188 | ▲18.086 | ▲14.622 |
| Price To Earnings Diluted Ratio | 48.142 | ▼-28.850 | ▼-22.197 |
| Price To Earnings Diluted Growth Ratio | 18.775 | ▲15.629 | ▲12.652 |
| Price To Book Ratio | 33.297 | ▼-22.087 | ▼-8.597 |
| Price To Sales Ratio | 9.692 | ▼-6.202 | ▼-3.251 |
| Price To Free Cash Flow Ratio | 28.022 | ▼-29.837 | ▼-19.875 |
| Price To Operating Cash Flow Ratio | 26.910 | ▼-29.247 | ▼-19.654 |
| Debt To Assets Ratio | 0.134 | ▲0.071 | ▲0.076 |
| Debt To Equity Ratio | 0.357 | ▲0.197 | ▲0.210 |
| Debt To Capital Ratio | 0.263 | ▲0.125 | ▲0.142 |
| Long Term Debt To Capital Ratio | 0.151 | ▲0.151 | ▲0.121 |
| Financial Leverage Ratio | 2.667 | ▲0.134 | ▲0.209 |
| Working Capital Turnover Ratio | 9.388 | ▼-0.253 | ▲1.759 |
| Operating Cash Flow Ratio | 0.854 | ▲0.117 | ▲0.139 |
| Operating Cash Flow Sales Ratio | 0.360 | ▲0.077 | ▲0.076 |
| Free Cash Flow Operating Cash Flow Ratio | 0.960 | ▼-0.010 | ▼-0.010 |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | 3.466 | ▼-2.706 | ▼-5.398 |
| Capital Expenditure Coverage Ratio | 25.197 | ▼-8.809 | ▼-11.731 |
| Dividend Paid And Capex Coverage Ratio | 25.197 | ▼-8.809 | ▼-11.731 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 35.126 | ▼-24.732 | ▼-18.321 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $10.48B | $16.57B | $13.31B | $7.62B | $9.87B | |
| Enterprise value | $10.26B | $16.35B | $13.06B | $7.41B | $9.62B | |
| EV / Sales | 9.49x | 15.68x | 14.06x | 9.66x | 14.50x | |
| EV / Op. cash flow | 26.35x | 55.42x | 53.03x | 41.24x | 51.97x | |
| EV / Free cash flow | 27.44x | 57.10x | 54.07x | 42.81x | 53.12x | |
| EV / EBITDA | 35.13x | 59.86x | 59.51x | 44.96x | 67.78x | |
| Net debt / EBITDA | -0.74x | -0.80x | -1.15x | -1.28x | -1.69x | |
| Current ratio | 1.28x | 1.26x | 1.31x | 1.32x | 1.64x | |
| Income quality | 1.77x | 1.35x | 1.39x | 1.39x | 1.68x | |
| Graham number | $21 | $20 | $17 | $13 | $12 | |
| Graham net-net | -$1 | -$1 | $0 | $0 | $1 | |
| Tax burden | 76.9% | 81.8% | 82.6% | 81.6% | 82.4% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | $127.4M | $103.0M | $113.3M | $99.8M | $159.4M | |
| Invested capital | $263.2M | $227.1M | $208.9M | $192.6M | $262.8M | |
| Return on assets | 26.2% | 28.8% | 26.2% | 22.6% | 20.5% | |
| Operating ROA | 35.4% | 36.6% | 33.8% | 27.5% | 26.7% | |
| Return on tangible assets | 28.3% | 31.4% | 28.9% | 25.4% | 23.1% | |
| Return on equity | 69.9% | 73.0% | 63.5% | 56.9% | 44.1% | |
| Return on invested capital | 56.7% | 59.9% | 56.4% | 48.9% | 38.1% | |
| Return on capital employed | 73.7% | 73.2% | 68.3% | 60.0% | 46.2% | |
| Earnings yield | 2.1% | 1.3% | 1.3% | 1.7% | 1.1% | |
| Free cash flow yield | 3.6% | 1.7% | 1.8% | 2.3% | 1.8% | |
| Capex / Op. cash flow | 4.0% | 2.9% | 1.9% | 3.7% | 2.2% | |
| Capex / Depreciation | 244.7% | 137.7% | 82.2% | 98.9% | 50.7% | |
| Capex / Sales | 1.4% | 0.8% | 0.5% | 0.9% | 0.6% | |
| SG&A / Sales | 16.2% | 15.9% | 16.8% | 17.9% | 19.0% | |
| R&D / Sales | 13.4% | 13.2% | 13.7% | 14.6% | 14.7% | |
| Stock comp / Sales | 10.3% | 8.9% | 7.7% | 7.7% | 6.5% | |
| Intangibles / Total assets | 7.4% | 8.2% | 9.2% | 10.9% | 11.5% | |
| Days sales outstanding | 72d | 74d | 72d | 80d | 70d | |
| Days payables outstanding | 17d | 20d | 20d | 26d | 23d | |
| Operating cycle | 72d | 74d | 72d | 80d | 70d | |
| Cash conversion cycle | 56d | 53d | 51d | 54d | 46d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-14 MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).
- 2026-08-14 Chuck Royce''s Second Quarter 2026 13F: Catalyst Pharmaceuticals Reduction Leads Portfolio Shifts A Deep Dive into the Small-Cap Pioneer''s Latest Moves, Including a -0.42% Impact from Exiting a Major StakeCharles M. Royce, a pioneer of small-cap investing an
- 2026-08-13 Manhattan Associates Inc (MANH) Stock Up 4.3% and Still Undervalued -- GF Score: 91/100 On August 13, 2026, Manhattan Associates Inc (MANH) shares rose 4.3% to a current price of $200.92. This price is notably within a 52-week range of $119.06 to $
- 2026-08-11 MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH). If you currently own shares of Manhattan Associates stock, please visit the firm''s website at https://rosenlegal.com/submit-form/?case_id=35966 for more information.
- 2026-08-08 MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. - MANH New York, Aug. 08, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).
- 2026-08-07 Manhattan Associates (MANH) Now Trades Above Golden Cross: Time to Buy? Manhattan Associates, Inc. (MANH) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MANH''s 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
- 2026-08-07 Manhattan Associates (MANH) is a Top-Ranked Momentum Stock: Should You Buy? Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 2026-08-05 MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).
- 2026-08-02 Manhattan Associates, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. - MANH Manhattan Associates, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers o
- 2026-08-02 Manhattan Associates, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. - MANH NEW YORK, Aug. 2, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH). If you currently own shares of Manhattan Associates stock, please visit the firm''s website at https://rosenlegal.com/submit-form/?case_id=35966 for more information.